Journal article
Health Technology Agency insights: informing modification of a qualitative benefit risk framework for Health Technology Reassessment of prescription medications
Abstract
OBJECTIVES: This study's intent was to determine if a qualitative benefit risk framework could be used or modified to further enable Health Technology Reassessment (HTR) of prescription medicine recommendations. The purpose of this research was to understand Canadian Health Technology Agency assessors past experiences and insights to inform any modifications to the Universal Methodology for Benefit-Risk Assessment (UMBRA) qualitative framework. …
Authors
Maloney MA; Schwartz L; O'Reilly D; Levine M
Journal
International Journal of Technology Assessment in Health Care, Vol. 35, No. 5, pp. 384–392
Publisher
Cambridge University Press (CUP)
Publication Date
2019
DOI
10.1017/s026646231900062x
ISSN
0266-4623